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Iliac artery-ureteral fistula is a rare entity that is being reported with increasing frequency. 
Patients with iliac artery-ureteral fistulas can be divided into two distinct groups on the 
basis of the factors that predispose them to having these fistulas. In group I the fistula is 
associated with degenerative iliac artery disease or previous arterial reconstructive surgery. 
Patients in group I I  have undergone some combination of the following procedures: pelvic 
extirpative surgery for malignancy, urinary diversion, radiation therapy, and ureteral 
stenting. The diagnosis of an iliac artery-ureteral fistula can be elusive ven with the use of 
multiple imaging methods. Direct operative repair is technically demanding and is 
associated with high mortality rates. In recent years, treatment has shifted toward 
percutaneous embolization of the iliac artery and extraanatomic lower extremity vascular 
reconstruction for group I I  patients. In this report, the 24 group I I  patients with iliac 
artery-ureteral fistulas who previously have been described are reviewed, and a new 
endovascular treatment for this entity that uses a stented vein graft is detailed. (J Vase Surg 
1996;24:680-6.) 
Communication between the iliac artery and the 
ureter is a rare event that has the potential for 
life-threatening hemorrhage. To date more than 60 
cases have been reported in the world literature; half 
of  the cases have appeared uring the past 10 years. A 
number of underlying conditions are known to be 
predisposing factors in the development of an iliac 
artery-ureteral fistula (IAUF). These factors include 
pelvic extirpative surgery, vascular reconstructive sur- 
gery, extensive ureteral mobilization, infection, irra- 
diation, ureterolithiasis, diverting urinary conduit 
construction, atherosclerotic and aneurysmal disease 
of the aortoiliac segment, and indwelling ureteral 
stents. At least one and often many of these factors 
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coexist in a given patient. Increasing recognition and 
greater experience in treating this entity have de- 
creased the associated mortality rate and improved 
the morbidity rate. Unfortunately, many of these 
patients continue to have complications because of 
diagnostic uncertainty, technical challenges associ- 
ated with treatment, surgical misadventures, and 
associated comorbid conditions. This report de- 
scribes a typical case of IAUF, details a new endovas- 
cular therapeutic option for its management, and 
reviews the literature concerning this entity. 
CASE REPORT 
The patient was a 67-year-old woman who underwent 
total abdominal hysterectomy and bilateral salpingo- 
oophorectomy at another institution in 1974 for stage IIB 
squamous cell carcinoma of the cervix. The surgery was 
followed by external-beam and interstitial irradiation, 
which cured the malignancy. The patient subsequently had 
multiple complications related to the radiation and v~as 
transferred to Barnes Hospital in 1994, when a large 
rectovaginal fistula developed. The fistula was managed 
with an end-sigmoid colostomy for fecal diversion. Later 
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that same year a large vesicovaginal fistula developed and 
was managed with ileal-loop conduit construction for 
urinary diversion. At that operation, the ureters were 
stented with 7F stents. The patient's postoperative course 
was complicated by a midline wound infection that required 
daily debridement and packing. In addition, the patient had 
poor drainage of urine, and the ureteral stents were in- 
creased in size to 12F on the twenty-first day after surgery, 
just before hospital discharge. 
The patient returned to the emergency department 8 
weeks later with complaints of left-side flank pain and gross 
hematutia from the ileal-loop conduit. On exam, the patient 
had a normal blood pressure with a resting tachycardia, nd 
the midline wound was not healed. Clotted blood was 
present in the ileal conduit collecting system, but no 
evidence of active bleeding was present. The left ureteral 
stent could not be flushed, and the right stent was draining 
clear urine. The patient's hematocrit level was 28%, and the 
platelet count and coagulation profile were within the 
normal imits. After admission but before left stent evalua- 
tion, hematuria recurred and was followed by hypotension. 
The patient was given a transfusion of 4 units of packed red 
blood cells for a hematocrit level of 23% and was transferred 
to the intensive care unit while arrangements were made for 
urgent radiologic evaluation. 
In the radiology suite, an attempt was made to better 
define the position of the left ureteral stent by contrast 
injection, but this attempt failed because ofstent occlusion. 
The stent hen was removed over a guidewire, and torrential 
arterial hemorrhage into the ileal conduit collecting system 
resulted. Immediate replacement of the stent achieved 
tamponade. Vascular surgical consultation was requested, 
and pelvic arteriography was initiated. The initial arterio- 
gram failed to show any abnormality. The pelvic arterio- 
graphic study then was repeated after again removing the 
ureteral stent over a guidewire. This scan demonstrated 
contrast extravasation i to the left ureter from the left 
common iliac artery (Fig. 1). Because of the previous 
extensive abdominopelvic surgery and irradiation, a direct 
operative approach was deemed extremely hazardous. Fur- 
thermore, because of the open lower-abdominal wound and 
the left lower quadrant colostomy, it was thought hat the 
patient would not be a good candidate for percutaneous 
iliac artery occlusion and extraanatomic bypass. As such, we 
elected to proceed with placement of an endoluminally 
placed, stented vein graft. 
The patient was transferred to the operating suite for 
the remainder of the procedure. After sterile preparation of 
the left groin, the femoral vessels were dissected and 
isolated. The profunda femoris vein was mobilized, and a 
large branch was dissected for several centimeters and then 
removed. The vein segment then was stripped ofadventitia, 
mounted over a Palmaz stent (P308M, 8 to 12 mm 
expansion, 30 mm length, Johnson and Johnson Interven- 
tional System, Warren, N.J.) and secured with polypro- 
pylene suture as described by Parodi.1 The resulting stented 
vein graft was mounted on a 10-mm angioplasty balloon 
catheter. A 13F introducer sheath was advanced into the left 
common iliac artery through a femoral arteriotomy. The 
balloon catheter/stented graft assembly then was intro- 
duced through the sheath to the level of the fistula. After 
withdrawal of the sheath, the stented graft was placed by 
inflating the angioplasty balloon. Repeat arteriography 
demonstrated closure of the fistula. The arteriotomy and 
groin wound were closed, and the left ureteral stent was 
replaced. The patient tolerated the procedure without 
difficulty, had no further episodes of hematuria, and was 
treated with 72 hours of broad-spectrum antibiotics. A 
repeat arteriogram was obtained on the seventh day after 
surgery, and the results were consistent with a good 
technical result (Fig. 2). The left ureteral stent was left in 
place for the next I2 weeks and then removed. The patient 
continues to do well without recurrence of the fistula or 
need for further urologic or surgical procedures at 12 
months of follow-up. 
DISCUSSION 
IAUF remains arare cause of  gross hematuria, but 
it is one that is being reported with increasing 
frequency. The literature is replete with scattered case 
reports, but little cumulative experience has been 
gained at any single institution. Many of  the early 
reports o f  IAUFs are mainly o f  historic significance 
today. In 1908, Moschcowitz 2 reported the first case, 
which occurred after bilateral ureterolithotomies and 
was treated with bilateral two-point ligation o f  the 
external iliac arteries. Several other early reports also 
document IAUFs after ureterolithotomy, s-5 In the 
1930s three patients died from massive hemorrhage 
when IAUFs developed after ureteral stent placement 
for hydronephrosis associated with pregnancy. 6-s In 
addition, three reports describe IAUFs after pro- 
longed drainage of  an appendectomy site, 9 after a 
gunshot wound,  l° and in association with an iliac 
arteriovenous malformation,  
Contemporary patients who have IAUFs can be 
separated into two groups that are pertinent to 
current clinical practice. In the first group, the fistula 
is associated with primary arterial disease and may be 
the result o f  mycotic aneurysm, s degenerative athero- 
sclerotic aneurysm, 12,13 or anastomotic pseudoaneu- 
rysm. 14,1s It  may also be associated with patch angio- 
plasty, 16 endarterectomy, 17 and vascular bypass graft- 
ingJ  8-2° This group has been succinctly described in 
several excellent reviews and 'will not  be discussed 
further here. The second group comprises patients 
who have undergone some combination of  the fol- 
lowing procedures: extirpative surgery for peMc or 
abdominal malignancy, extensive ureteral mobiliza- 
tion, urinary diversion procedure, external-beam or 
intercavitary irradiation, and prolonged ureteral 
stenting. The remainder o f  this report will focus on 
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Fig. 1. Pelvic arteriogram after removal of left ureteral stent. A, Immediately after contrast 
injection, note small amount of contrast in left ureter at arrow. B, Later image shows more 
contrast in left ureter at arrow. Note presence of guidewire in left ureter. 
Fig. 2. Pelvic arteriogram, obtained on seventh day aftcr 
surgery with ureteral stent removed emonstrates good 
technical result and no evidence of IAUF. 
this group because it represents the most frequent 
association with IAUFs and because itwill be the most 
likely to benefit from endovascular intervention. 
Twenty-four cases of lAUF associated with pelvic 
malignancy resection, irradiation, ureteral mobiliza- 
tion, and indwelling ureteral stents have previously 
been described in the English literature. 21-36 Three 
additional cases of  fistula formation between the 
common iliac artery and the ileal urinary conduit in 
this type of patient have also been reported and are 
included in this report. 37'38 Details of these 27 cases 
are presented in Table I. Nine were men and 18 were 
women; their ages ranged from 21 to 81 years, with an 
average of 58 years. All of the patients had been 
treated with extensive surgical resection for pelvic or 
abdominal malignancy. The specific tumor types en- 
compass a narrow spectrum: epidermoid carcinoma 
of the cervix (11 patients, 41%); transitional cell 
carcinoma of the urinary bladder (10 patients, 37%); 
adenocarcinoma of the uterus (3 patients, 11%); or 
adenocarcinoma of the colon (3 patients, 11%). Ex- 
ternal-beam radiation therapy, interstitial radiation 
therapy, or both had been used in 21 patients (78%). 
Ileal urinary conduits were present in 17 (63%), 
cutaneous ureterostomy in 6 (22%), and 4 patients 
(15%) had ureters in the normal anatomic position. 
Ureteral stents were present in 23 patients ( 85 %), and 
3 of the 4 without stents were those in whom the 
fistulous communication with the urinary tract was via 
the ileal conduit. The common iliac artery was the 
source of the fistula in 25 cases (93%). The internal 
iliac and external i iac arteries were the source of the 
fistula in the other two. 
The pathophysiologic mechanism of IAUF re- 
mains poorly understood; many factors have a poten- 
tial role. It is possible that the ureteral stent provides 
a firm strut against which arterial pulsation is continu- 
ously transmitted toa compromised ureter. Radiation 
therapy, surgery, and urine leaks are all probably 
responsible for the intense fibrotic, inflammatory 
response that fixes the ureter to the artery. Pressure 
necrosis of the ureter probably occurs under these 
circumstances and may be the initiating event in 
formation of the fistula. Abnormalities of the iliac 
artery, including radiation change and native aneu- 
rysmal disease, further increase the risk. 
The importance of obtaining the correct preop- 
erative diagnosis cannot be overemphasized. In 12 
patients who were explored without the correct 
preoperative diagnosis, seven died, yielding a mortal- 
ity rate of 58%. I f  the two additional patients 22,31 
without a correct diagnosis who exsanguinated before 
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Tab le  I.  Summary of  clinical data. 
Author/year Sex~age History Imaging tests Dx* Therapy Result 
Beaugie/1971"~ M/63 TCC bladder, cystectomy, conduit, None No Exp lap, fistula to conduit, iliac Died 
RT graft, conduit revision 
Reiner/1975 F/75 SCC Cx, pelvic exenteration, con- None No Exp lap, repair iliac, ureterostomy Died 
duit, RT, ureteric T tube 
Thiry/1980 M/68 TCC bladder, cystectomy, conduit, IVP - No None, exsanguination before Died 
iliac artery aneurysm ruptured RA - surgery 
into ureter at 1 yr Ao - 
Smith/1984 M/67 TC bladder, cystectomy, RT, con- None No Exp lap, repair lilac, excision Lived 
duit, + stent conduit/ureter, nephrostomy 
Toolin/1984 F/21 SCC Cx, pelvic exenteration, RT, IVP- Yes Renal embolization, lilac artery Lived 
conduit, + stent Ao- embolization 
SMA- 
IA- 
BOU+ 
RA- 
IA- 
Veno- 
TCC bladder, cystectomy, conduit, NG- No Renal embolization, ephrectomy, Died 
+ stent Ao- exsanguination 
RA- 
Ao- 
RU+ 
Rid+ 
ICar/1984 F/72 
Adams/1984 F/66 
Dauplet/1985 F/51 
M/68 
Ahlborn/1986 M/73 
Keller/1990 F/53 
Zweers/1991 
Adenoca colon, colectomy, RT, 
ureterolithotomy, + stent 18 mo 
Adenoca uterus, pelvic exentera- 
rion, RT, conduit + stent 
TCC bladder, cystectomy, cutane- 
ous ureterostomy, + stent, iliac 
aneurysm 
TCC bladder, cystectomy, conduit, 
+ stent 15 months 
No Exp lap, repair lilac, iigate ureter, Lived 
nephrosotomy 
Yes Angiographic lilac occlusion, fem- Lived 
fern bypass 
Yes Exp lap, repair iliac, revision ure- Died 
terostomy 
RA- No Exp lap, ligate lilac, nephrectomy, Lived 
SMA- fem-fem bypass 
IMA- 
SCC Cx, pelvic exenteration, RT, Ao- Yes Angiographic liac occlusion, fem- Lived 
conduit, + stent RA- fern bypass 
SMA- 
IA+ 
F/43 SCC Cx, pelvic exenterarion, RT, IA+ Yes Angiographic iliac occlusion, fern- Lived 
conduit, + stent fern bypass 
F/34 SCC Cx, TAH + BSO, RT, + stent US- No Renal embofization, ephrectomy Lived 
Ao- for recurrent bleeding, exp lap 
RA- 24 hr later, repair lilac, resect re- 
IA- maining ureter 
BOU- 
IA- 
TCC, Transitional cell carcinoma; SCC Cx, squamous cell carcinoma of ther cervix; Adenoca, denocardnoma; RT, radiation therapy; 
TAH+ BSO, total abdominal hysterectomy + bilateral salpingooophorectomy; IVP, intravenous pyelography;/CA_, renal arteriography; Ao, 
aortography; SMA, superior mesenteric arteriography; IMA, inferior mesenteric arteriography; IA, ifiac arteriography; Veno, venography; 
NG, nephrostography; RU, retrograde ureterography; BOU, balloon occlusion ureterography; CT, cytoscopy; Exp lap, exploratory 
laparotomy; femfem, femorofemoral bypass; US, ultrasound. 
*Correct preprocedure diagnosis; **selective repeat arteriography after stent removal with active bleeding. 
tlndicates patient with fistula from iliac artery to ileal conduit. 
explorat ion are included, the mortal i ty rate for this 
group increases to 64%. Conversely, when the correct 
diagnosis was made before surgery, the mortal i ty rate 
for the 12 treated patients was 8% (one patient is 
excluded because treatment was withheld even 
though the correct diagnosis was made34). No  single 
test is diagnostic in all cases o f  IAUF,  and most  cases 
required use o f  mult iple imaging methods,  as can be 
seen in Table I. O f  the 13 patients in whom the correct 
diagnosis was obtained,  the fistula was identif ied by 
ureterography in four, ureteroscopy in one, and by 
selective iliac artery arter iography in eight. Both 
ureterography and arter iography identif ied the fistula 
in one case. In recent years, diagnostic accuracy has 
improved with the recognit ion that IAUFs  bleed 
intermittent ly and with the institution o f  maneuvers 
designed to provoke renewed hemorrhage.  These 
include high-pressure bal loon occlusion pyeloureter- 
ography, ureteral stent removal (over a wire), mult iple 
obl ique views, selective arterial injection, and produc-  
t ion o f  friction in the ureteral umen by to-and-fro 
mot ion  o f  ureteral catheters in an effort to dislodge 
any occluding thrombus.  24'29'36'39 The diagnostician 
must be prepared to deal with torrential  hemorrhage 
should this occur dur ing ureteric manipulat ion. Re- 
placement o f  the ureteral stent or inflation o f  an 
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Table I. cont'd. 
Author~year Sex/age History Imaging tests Dx* Therapy Result 
Dervanian/1992 F /58  SCC Cx, pelvic exenteration, RT, Ao- No Exp lap, ligation ofiliac and IMA, Lived 
cutaneous ureterostomy, colos- RA- ligation of ureter 
tomy, + stent 
F /60  SCC Cx, pelvic exenteration, RT, None No Manipulation of stent resulted in Died 
cutaneous ureterostomy, + stent exsanguination 
17 months 
M/62 TCC bladder, cystectomy, cutane- Ao- No Exp lap, bifurcated graft for iliac Lived 
ous ureterostomy, + stent aneurysm/fistula, ligation of 
ureter 
Puppo/1992 M/81 TCC bladder, cystectomy, cutane- Ao- No Exp lap, ligation ofiliac, fem-fem Lived 
ous ureterostomy, RT, + stent RA- bypass, resect ureter, 
IA- nephrostomy 
RU-  
None Wampler/1992 F /49  
M/aS 
Gelder/i993 F /53  
F/43 
Hauenstein/1993 F /37  
Shutze/1993 M/59 
Quillan/1994 F /36  
F /74  
F/53 
F /64  
SCC Cx, pelvic exenteration, con'- 
duit, sigmoid colostomy, RT, 
postop urine leak, 
Adenoca colon, colectomy, plevic 
exenteration for recurrent dis- 
ease, conduit 
SSC Cx, pelvic exenteration con- 
duit, RT, + stent 
SCC Cx, TAH + BSO, RT, pelvic 
exenteration for recurrence, 
conduit, + stent 
Adenoca uterus, TAIt + BSO, RT, 
vesicovaginal fistula, ureteros- 
tomy, + stent 
Adenoca rectum, pelvic exentera- 
tion, conduit, RT, + stent 
SCC Cx, TAH + BSO, RT, + stent 
TCC bladder, conduit, peMc ex- 
enteration, RT, + stent, iatro- 
genie IAUF during ureteral 
stricture incision 
TCC bladder, cystectomy, conduit, 
RT, + stent 
Adenoca uterus, RT, + stent 
Ao- 
No Exp lap, fistula to conduit, ligation Died 
ofiliac, fem-fem bypass excision 
of conduit 
No Exp lap, fistula to conduit, repair Died 
of iliac, conduit revision 
Ao- Yes 
IA- 
IA+ 
Ao- Yes 
IA- 
IA+** 
Ao- Yes 
IA+ 
Angiographic liac occlusion, fem- Lived 
fern bypass 
Angiographic liac occlusion, fern- Lived 
fern bypass 
Treatment withheld, poor surgical Died 
candidate 
Ao- Yes Femoral arteriotomy, balloon oc- Lived 
CY+ clusion ilLac fern-fern bypass 
IA+ Yes Angiographic liac occlusion, fern- Lived 
RU+ fern bypass 
IA+ Yes Exp lap, repair ofiliac Lived 
Ao- Yes Angiographic liac occlusion, fem- 
IA- fem bypass 
IA+** 
Ao- Yes Angiographic liac occlusion, fem- 
IA+ fem bypass 
Lived 
Lived 
angioplasty balloon are two methods that have been 
described and should control hemorrhage while 
therapeutic options are considered? 6 
Prevention of IAUFs with their attendant compli- 
cations is desirable, and technical considerations to
accomplish this objective have been suggested. 4°m 
Despite the use of these prophylactic measures, 
IAUFs will continue to occur and require treatment. 
Although recent improvements in diagnostic accu- 
racy have reduced the mortality rate for IAUFs, 
improved therapeutic techniques have also had a 
significant impact. Of the 27 patients in this review, 13 
had a direct surgical approach to the IAUF. Of these, 
four were treated with ligation of the iliac artery (three 
required subsequent femorofemoral bypass), seven 
had suture repair of the artery, and two had replace- 
ment of the involved arterial segment with a pros- 
thetic graft. The hazards associated with direct explo- 
ration in these technically challenging cases are well 
known and include the need to operate through 
previously dissected, fibrotic tissue planes, and the risk 
of injury to friable bowel, ureters, and blood vessels. 
Furthermore, if the surgeon is successful in control- 
ling the arterial portion of the fistula, the ureter and 
ileal conduit must often be revised or removed. If 
ligation of the artery is required, many of these ill 
patients then must be submitted to ipsilateral lower 
extremity revascularization. The severe physiologic 
stress that accompanies this approach may result in 
multiple-organ dysfunction and death in patients who 
survive the operation. Angiographic vascular occlu- 
sion proximal and distal to the origin of the fistula 
accomplishes the same goal as open procedures, and 
together with cxtraanatomic vascular econstruction 
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of the lower extremity is currently the recommended 
treatment. Of the 10 patients treated with balloon or 
coil embolization in this review, eight required sub- 
sequent fcmorofemoral bypass (axillofemoral bypass 
is also an option) and the other two did not require 
arterial reconstruction. As well as avoiding abdominal 
surgery in these ill patients, this approach does not 
force repair of the ureteral component of the fistula 
(most patients have required continued short-term 
ureteral stenting, and no untoward effects have been 
reported to date). Unfortunately, the extraanatomic 
vascular repair may be associated with a myriad of 
problems, including inadequate inflow source, sub- 
optimal patency rates, recurrent thrombosis, and 
infected or contaminated tissue planes along pro- 
posed graft routes. 
Endovascular grafting allows a variety of vascular 
lesions to be treated with minimally invasive tech- 
niques. Although this technology is still in the devel- 
opmental phase, it has been used to treat a wide variety 
of lesions, including thoracic 42 and abdominal aneu- 
rysms, 1'43 traumatic pseudoaneursyms, TM arterio- 
venous fistulae, 44 and atherosclerotic occlusive dis- 
ease.45 This is the first case report that describes endo- 
vascular grafting to treat an IAUF. In this setting, 
endovascular grafting appears to provide many of the 
essential features of ideal therapy. These features in- 
clude closure of the fistula, maintenance ofprograde 
iliac artery flow, avoidance of the need for direct 
artcrial/ureteral surgery, and avoidance of subse- 
quent procedures to revascularize the lower extrem- 
ity. The profunda femoris vein was selected to cover 
the stent because it is the preferred conduit in con- 
taminated fields, has a thin wall that allows for a low 
profile, has less smooth muscle with less recoil, and has 
a superior size match for the common iliac artery 
when compared with superficial veins. Unfortunately, 
the effect of continued urctcral stenting and the prob- 
ability of recurrent fistulization in this setting are not 
known. Ideally, the urcteral stent should be removed 
as soon as clinically indicated. If conduit revision is 
required, it then could be undertaken in a stable, 
properly prepared patient. Long-term patency rates 
have not been reported for any of the situations in 
which endovascular grafting has been used, but when 
used in this setting long-term patency rates might be 
expected to be as good as or better than the already 
excellent results reported for the use of uncovered 
Palmaz stcnts in iliac artery occlusive disease. 46 In pa- 
tients who have an IAUF as a result of pelvic resection 
for malignancy, urinary diversion, radiation therapy, 
and indwelling ureteral stents, endovascular grafting 
provides a new and attractive therapeutic option. 
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